Andrew R. Rahmberg

Andrew R. Rahmberg

Auto-generated profile, based on publicly available information

Andrew R. Rahmberg

Barrier Immunity Section, Lab of Viral Diseases, NIAID, NIH, Bethesda, MD, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2023 in Communications Biology
Verified
Journal Article
Open access
PDF file
JRJames R. Rose
James R. Rose
BABagdeser Akdogan-Ozdilek
Bagdeser Akdogan-Ozdilek
ARAndrew R. Rahmberg
Andrew R. Rahmberg
MPMichael D. Powell
Michael D. Powell
SHSakeenah L. Hicks
Sakeenah L. Hicks
JBJeremy M. Boss
Jeremy M. Boss
Human memory T cells (MTC) are poised to rapidly respond to antigen re-exposure. Here, we derived the transcriptional and epigenetic programs of resting and ex vivo activated, circulating CD4+ and CD8+ MTC subsets. A progressive gradient of gene expression from naïve to TCM to TEM is observed, which is accompanied by corresponding changes in chromatin accessibility. Transcriptional changes suggest adaptations of metabolism that are reflected in altered metabolic capacity. Other differences involve regulatory modalities comprised of discrete accessible chromatin patterns, transcription factor binding motif enrichment, and evidence of epigenetic priming. Basic-helix-loop-helix factor motifs for AHR and HIF1A distinguish subsets and predict transcription networks to sense environmental changes. Following stimulation, primed accessible chromatin correlate with an augmentation of MTC gene expression as well as effector transcription factor gene expression. These results identify coordinated epigenetic remodeling, metabolic, and transcriptional changes that enable MTC subsets to ultimately respond to antigen re-encounters more efficiently.

17 June 2024 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
ZSZachary Strongin
Zachary Strongin
LMLaurence Raymond Marchand
Laurence Raymond Marchand
CDClaire Deleage
Claire Deleage
MPM. Betina Pampena
M. Betina Pampena
MCMaria Andrea Cardenas
Maria Andrea Cardenas
MPMirko Paiardini
Mirko Paiardini

21 November 2019 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
PMParimal Majumder
Parimal Majumder
JLJoshua T. Lee
Joshua T. Lee
ARAndrew R. Rahmberg
Andrew R. Rahmberg
GKGaurav Kumar
Gaurav Kumar
TMTian Mi
Tian Mi
JBJeremy M. Boss
Jeremy M. Boss
Super enhancers (SEs) play critical roles in cell type–specific gene regulation. The mechanisms by which such elements work are largely unknown. Two SEs termed DR/DQ-SE and XL9-SE are situated within the human MHC class II locus between the HLA-DRB1 and HLA-DQA1 genes and are highly enriched for disease-causing SNPs. To test the function of these elements, we used CRISPR/Cas9 to generate a series of mutants that deleted the SE. Deletion of DR/DQ-SE resulted in reduced expression of HLA-DRB1 and HLA-DQA1 genes. The SEs were found to interact with each other and the promoters of HLA-DRB1 and HLA-DQA1. DR/DQ-SE also interacted with neighboring CTCF binding sites. Importantly, deletion of DR/DQ-SE reduced the local chromatin interactions, implying that it functions as the organizer for the local three-dimensional architecture. These data provide direct mechanisms by which an MHC-II SE contributes to expression of the locus and suggest how variation in these SEs may contribute to human disease and altered immunity.

24 January 2024 in Blood Advances
Verified
Journal Article
Open access
PDF file
ARAndrew R. Rahmberg
Andrew R. Rahmberg
CWChuanfeng Wu
Chuanfeng Wu
TSTaehoon Shin
Taehoon Shin
SHSo Gun Hong
So Gun Hong
LPLuxin Pei
Luxin Pei
JBJason M. Brenchley
Jason M. Brenchley
Macrophages orchestrate tissue immunity from the initiation and resolution of antimicrobial immune responses to the repair of damaged tissue. Murine studies demonstrate that tissue-resident macrophages are a heterogenous mixture of yolk sac–derived cells that populate the tissue before birth, and bone marrow–derived replacements recruited in adult tissues at steady-state and in increased numbers in response to tissue damage or infection. How this translates to species that are constantly under immunologic challenge, such as humans, is unknown. To understand the ontogeny and longevity of tissue-resident macrophages in nonhuman primates (NHPs), we use a model of autologous hematopoietic stem progenitor cell (HSPC) transplantation with HSPCs genetically modified to be marked with clonal barcodes, allowing for subsequent analysis of clonal ontogeny. We study the contribution of HSPCs to tissue macrophages, their clonotypic profiles relative to leukocyte subsets in the peripheral blood, and their transcriptomic and epigenetic landscapes. We find that HSPCs contribute to tissue-resident macrophage populations in all anatomic sites studied. Macrophage clonotypic profiles are dynamic and overlap significantly with the clonal hierarchy of contemporaneous peripheral blood monocytes. Epigenetic and transcriptomic landscapes of HSPC-derived macrophages are similar to tissue macrophages isolated from NHPs that did not undergo transplantation. We also use in vivo bromodeoxyuridine infusions to monitor tissue macrophage turnover in NHPs that did not undergo transplantation and find evidence for macrophage turnover at steady state. These data demonstrate that the life span of most tissue-resident macrophages is limited and can be replenished continuously from HSPCs.

22 February 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
QHQuentin Le Hingrat
Quentin Le Hingrat
PSPaola Sette
Paola Sette
CXCuiling Xu
Cuiling Xu
ARAndrew R. Rahmberg
Andrew R. Rahmberg
LTLilas Tarnus
Lilas Tarnus
IPIvona Pandrea
Ivona Pandrea
CD4+ T-cell depletion is a hallmark of HIV infection, leading to impairment of cellular immunity and opportunistic infections, but its contribution to SIV/HIV-associated gut dysfunction is unknown. Chronically SIV-infected African Green Monkeys (AGMs) partially recover mucosal CD4+ T-cells, maintain gut integrity and do not progress to AIDS. Here we assess the impact of prolonged, antibody-mediated CD4 + T-cell depletion on gut integrity and natural history of SIV infection in AGMs. All circulating CD4+ T-cells and >90% of mucosal CD4+ T-cells are depleted. Plasma viral loads and cell-associated viral RNA in tissues are lower in CD4+-cell-depleted animals. CD4+-cell-depleted AGMs maintain gut integrity, control immune activation and do not progress to AIDS. We thus conclude that CD4+ T-cell depletion is not a determinant of SIV-related gut dysfunction, when gastrointestinal tract epithelial damage and inflammation are absent, suggesting that disease progression and resistance to AIDS are independent of CD4+ T-cell restoration in SIVagm-infected AGMs.

19 September 2025 in Science Advances
Verified
Journal Article
Open access
DYDebra S. Yee
Debra S. Yee
JDJonathan P. Davies
Jonathan P. Davies
LVLaura A. VanBlargan
Laura A. VanBlargan
ARAndrew R. Rahmberg
Andrew R. Rahmberg
KBKatherine E. Burgomaster
Katherine E. Burgomaster
JBJason M. Brenchley
Jason M. Brenchley
An Oropouche virus (OROV) outbreak occurred in South America in 2024. The pathogenic potential and host immunological response of this emerging virus are largely unknown, as animal models have been poorly explored. We infected nonhuman primate (NHP) species with OROV and followed viral replication dynamics and subsequent innate and adaptive immunological responses. OROV efficiently replicated in pigtail macaques, rhesus macaques, and vervet African green monkeys. OROV also replicated in sabeus African green monkey, albeit at lower levels than other hosts. OROV RNA was detected in plasma and nasal swabs and infection-induced high levels of innate inflammation, type I interferon gene signatures, immunoglobulin M–positive B cell expansion, high titers of neutralizing antibodies, and detectable frequencies of OROV-specific T cells. Prior infection was protective against reinfection up to 524 days post–initial infection, demonstrating possible protective immunity induction against OROV infection. These data suggest that multiple NHP species are appropriate models for OROV infection and the development of therapeutics and vaccinations.